LON:GENI GENinCode (GENI) Share Price, News & Analysis GBX 0.80 -0.06 (-6.47%) As of 10:01 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock About GENinCode Stock (LON:GENI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get GENinCode alerts:Sign Up Key Stats Today's Range 0.76▼ 0.9050-Day Range 0.79▼ 1.2752-Week Range 0.76▼ 5.50Volume5.85 million shsAverage Volume5.98 million shsMarket Capitalization£5.99 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide. GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U. GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset. Read More Receive GENI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GENinCode and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GENI Stock News HeadlinesGENinCode Shareholders Approve All Resolutions at Annual General MeetingJuly 1, 2026 | tipranks.comAIM Market Roundup: Marechale Capital, Genincode, BoohooJune 5, 2026 | uk.finance.yahoo.comTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no debate, no vote, one executive order. Gold tripled within three years and climbed 20x over the following decade. Trump holds that same executive authority today, and his advisors are openly saying a reversal is on the table. There are two ways this plays out - both move gold in the same direction. A free briefing breaks down exactly what Nixon did, why Trump is positioned to act, and how to move your 401k into gold before any announcement - tax free.July 14 at 1:00 AM | Reagan Gold Group (Ad)GENinCode slumps after it reprices optionsMay 7, 2026 | uk.finance.yahoo.comAIM Market Roundup: Phoenix Copper, Pipehawk, GenincodeFebruary 25, 2026 | uk.finance.yahoo.comGENinCode Raises £4.1m Following Completion of WRAP Retail OfferJanuary 26, 2026 | tipranks.comTRADING UPDATES: GENinCode to raise funds via placing and subscriptionJanuary 21, 2026 | lse.co.ukGENinCode Opens WRAP Retail Offer Alongside £3.5m Placing at Deep DiscountJanuary 21, 2026 | tipranks.comSee More Headlines GENI Stock Analysis - Frequently Asked Questions How have GENI shares performed this year? GENinCode's stock was trading at GBX 2.50 at the start of the year. Since then, GENI stock has decreased by 68.2% and is now trading at GBX 0.80. How were GENinCode's earnings last quarter? GENinCode Plc (LON:GENI) posted its quarterly earnings results on Monday, June, 8th. The company reported ($2.08) EPS for the quarter. The firm had revenue of $3.08 million for the quarter. GENinCode had a negative trailing twelve-month return on equity of 409.40% and a negative net margin of 185.47%. How do I buy shares of GENinCode? Shares of GENI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of GENinCode own? Based on aggregate information from My MarketBeat watchlists, some other companies that GENinCode investors own include Qualcomm (QCOM), Sound Energy (SOU), Zura Bio (ZURA), Capital One Financial (COF), Lincoln National (LNC), Ovid Therapeutics (OVID) and Plug Power (PLUG). Company Calendar Last Earnings6/08/2026Today7/14/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Diagnostics & Research Sub-IndustryEntertainment Current SymbolLON:GENI CIKN/A Webwww.genincode.com Phone44 1865 955 847FaxN/AEmployees2,300Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (2.08) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£6.10 million Net Margins-185.47% Pretax MarginN/A Return on Equity-409.40% Return on Assets-63.99% Debt Debt-to-Equity Ratio117.74 Current Ratio0.93 Quick Ratio15.89 Sales & Book Value Annual Sales£3.08 million Price / Sales1.95 Cash FlowGBX 0.95 per share Price / Cash Flow0.83 Book ValueGBX 1.63 per share Price / Book0.49Miscellaneous Outstanding Shares753,041,000Free FloatN/AMarket Cap£5.99 million OptionableNot Optionable Beta0.59 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (LON:GENI) was last updated on 7/14/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredConfirm Your Name Before the Letter Goes OutAmericans who believe in real retirement protection are adding their names to a statement going out to Washing...American Alternative | SponsoredThe $5 company SpaceX can’t survive withoutThe investors who got rich on AI didn't all buy Nvidia. Some bought ASML, the company that makes the machines ...Traders Agency | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | SponsoredWhen I found Rolls-Royce under $2, most people thought I was crazyIn 2022, Karim Rahemtulla recommended Rolls-Royce when it traded under $2. The stock climbed more than 1,100% ...Monument Traders Alliance | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | SponsoredThis Is How Financial Freedom Dies—And Most People Never See It ComingWhile the trade war grabs headlines, the Department of Justice has quietly argued in court that cash may not b...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GENinCode Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share GENinCode With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
